FDA Updates Plavix Labeling to Warn Against Co-Administration with Other CYP2C19 Inhibitors | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has updated the labeling for Plavix to warn consumers and doctors about the concomitant use of the anti-platelet agent and CYP2C19-inhibiting agents, such as the proton pump inhibitor Prilosec and others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.